Immunological Reviews is a dedicated immunology journal covering all areas of immunological research, including clinical immunology, experimental immunology, and studies of allergy and the immune system.

Articles

INVITED REVIEW
Open access

Using IMGT unique numbering for IG allotypes and Fc-engineered variants of effector properties and half-life of therapeutic antibodies

Marie-Paule Lefranc, Gérard Lefranc, 
  •  4 October 2024
INVITED REVIEW
Open access

Stellabody: A novel hexamer‐promoting mutation for improved IgG potency

Clarissa A. Whitehead, Bruce D. Wines, Anna M. Davies, James M. McDonnell, Halina M. Trist, Sandra E. Esparon, P. Mark Hogarth, 
  •  4 October 2024
INVITED REVIEW
Open access

The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals

Jasminka Krištić, Gordan Lauc, 
  •  4 October 2024
INVITED REVIEW
Open access

Antibodies in neurological diseases: Established, emerging, explorative

Lucie Y. Li, Amelya Keles, Marie A. Homeyer, Harald Prüss, 
  •  1 October 2024
INVITED REVIEW
Open access

Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis

Abhimanu Pandey, Zheyi Li, Manjul Gautam, Aritra Ghosh, Si Ming Man, 
  •  1 October 2024
More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

Overview of the IL-1 family in innate inflammation and acquired immunity

Charles A. Dinarello, 
  •  8-27
  •  16 December 2017

Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease

Joseph M. Pickard, Melody Y. Zeng, Roberta Caruso, Gabriel Núñez, 
  •  70-89
  •  30 August 2017

Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases

Si Ming Man, Rajendra Karki, Thirumala-Devi Kanneganti, 
  •  61-75
  •  30 April 2017

The PD‐1 pathway in tolerance and autoimmunity

Loise M. Francisco, Peter T. Sage, Arlene H. Sharpe, 
  •  219-242
  •  15 June 2010

Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis

Beatrix Bartok, Gary S. Firestein, 
  •  233-255
  •  23 December 2009
More articles
Open access

N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology

Benedict Boateng Antuamwine, Rebeka Bosnjakovic, Francisca Hofmann-Vega, Xi Wang, Theodosios Theodosiou, Ioannis Iliopoulos, Sven Brandau, 
Open access

Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family

Corinne Cayrol, Jean-Philippe Girard, 
Open access

Living in LALA land? Forty years of attenuating Fc effector functions

Geoff Hale, 
Open access

Neutrophils in aging and aging‐related pathologies

Kristof Van Avondt, Jan-Kolja Strecker, Claudia Tulotta, Jens Minnerup, Christian Schulz, Oliver Soehnlein, 
Open access

The role of neutrophils in trained immunity

Lydia Kalafati, Aikaterini Hatzioannou, George Hajishengallis, Triantafyllos Chavakis, 
Open access

Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines

Alessandro Sette, Shane Crotty, 
Open access

Trained immunity: General and emerging concepts

Patricia Vuscan, Brenda Kischkel, Leo A. B. Joosten, Mihai G. Netea, 
Open access

Macrophage defense mechanisms against intracellular bacteria

Günter Weiss, Ulrich E. Schaible, 
Open access

Engineering the IL-4/IL-13 axis for targeted immune modulation

Zachary J. Bernstein, Anjali Shenoy, Amy Chen, Nicola M. Heller, Jamie B. Spangler, 

Overview of the IL-1 family in innate inflammation and acquired immunity

Charles A. Dinarello, 

Recent issues

Latest news

More news >